• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SASLT practice guidelines for the management of hepatitis B virus.

作者信息

Abaalkhail Faisal, Elsiesy Hussien, AlOmair Ahmed, Alghamdi Mohammed Y, Alalwan Abduljaleel, AlMasri Nasser, Al-Hamoudi Waleed

机构信息

Department of Liver and Small Bowel Transplantation, King Faisal Specialist Hospital and Research Center; Gastroenterology Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Saudi J Gastroenterol. 2014 Jan-Feb;20(1):5-25. doi: 10.4103/1319-3767.126311.

DOI:10.4103/1319-3767.126311
PMID:24496154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3952421/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293d/3952421/9af16da0a4d2/SJG-20-5-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293d/3952421/af615452bb3f/SJG-20-5-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293d/3952421/9af16da0a4d2/SJG-20-5-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293d/3952421/af615452bb3f/SJG-20-5-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/293d/3952421/9af16da0a4d2/SJG-20-5-g005.jpg

相似文献

1
SASLT practice guidelines for the management of hepatitis B virus.乙型肝炎病毒管理的SASLT实践指南。
Saudi J Gastroenterol. 2014 Jan-Feb;20(1):5-25. doi: 10.4103/1319-3767.126311.
2
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.rtA194T聚合酶突变影响乙肝e抗原阳性和乙肝e抗原阴性乙肝病毒株的病毒复制及对替诺福韦的敏感性。
Hepatology. 2009 Apr;49(4):1158-65. doi: 10.1002/hep.22790.
3
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.在马拉维接受一线抗逆转录病毒治疗的艾滋病毒阳性成年人中，乙型肝炎病毒A1亚基因型感染的特点是复制水平高且耐药性迅速出现。
Clin Infect Dis. 2014 Dec 1;59(11):1618-26. doi: 10.1093/cid/ciu630. Epub 2014 Aug 6.
4
[Laboratory diagnosis of hepatitis B].[乙型肝炎的实验室诊断]
Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:7-14.
5
Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.巴西人类免疫缺陷病毒感染患者的乙型肝炎病毒感染模式：隐匿性感染的高流行率和拉米夫定耐药突变的低频率
Mem Inst Oswaldo Cruz. 2006 Sep;101(6):655-60. doi: 10.1590/s0074-02762006000600013.
6
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.乙型肝炎病毒对抗病毒药物的耐药性：当前情况及未来研究方向
Antivir Chem Chemother. 2001 Jan;12(1):1-35. doi: 10.1177/095632020101200101.
7
Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.一名同时感染艾滋病毒的患者因乙肝病毒拉米夫定耐药突变体导致暴发性乙型肝炎。
Gastroenterology. 2002 Jan;122(1):244-5. doi: 10.1053/gast.2002.30901.
8
Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.拉米夫定：一种在移植前环境中抑制乙肝病毒复制的新策略。
Transplant Proc. 2000 Dec;32(8):2642. doi: 10.1016/s0041-1345(00)01817-0.
9
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.存在拉米夫定耐药乙型肝炎病毒突变体时的血清拉米夫定水平。
Dig Liver Dis. 2004 Oct;36(10):677-81. doi: 10.1016/j.dld.2004.03.020.
10
Primary infection with a lamivudine-resistant hepatitis B virus.初次感染对拉米夫定耐药的乙型肝炎病毒。
AIDS. 2002 Jan 4;16(1):131-3. doi: 10.1097/00002030-200201040-00020.

引用本文的文献

1
Seroprotection of Hepatitis B Vaccine in Dental Students Two Decades after Infant Immunization and the Possible Need for Revaccination.婴儿免疫接种二十年后牙科学生中乙肝疫苗的血清保护作用及再次接种的可能需求
Eur J Dent. 2023 Feb;17(1):143-149. doi: 10.1055/s-0042-1743151. Epub 2022 Apr 18.
2
Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia.揭示乙型肝炎病毒为无声杀手：致沙特阿拉伯的行动呼吁。
Cureus. 2021 May 2;13(5):e14811. doi: 10.7759/cureus.14811.
3
SASLT practice guidelines for the management of Hepatitis B virus - An update.

本文引用的文献

1
APASL consensus statements and management algorithms for hepatitis C virus infection.亚太肝脏研究学会丙型肝炎病毒感染共识声明及管理算法
Hepatol Int. 2012 Apr;6(2):409-35. doi: 10.1007/s12072-012-9342-y. Epub 2012 Mar 1.
2
Correlation between hepatitis B surface antigen titers and HBV DNA levels.乙肝表面抗原滴度与 HBV DNA 水平的相关性。
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):252-7. doi: 10.4103/1319-3767.121035.
3
Predictors of significant fibrosis in chronic hepatitis B patients with low viremia.低病毒血症慢性乙型肝炎患者显著纤维化的预测因素
乙型肝炎病毒管理的 SASLT 实践指南更新版。
Saudi J Gastroenterol. 2021 May-Jun;27(3):115-126. doi: 10.4103/sjg.sjg_539_20.
4
Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study.换用富马酸替诺福韦艾拉酚胺后乙肝病毒患者的临床特征：一项回顾性观察研究
Cureus. 2020 Sep 11;12(9):e10380. doi: 10.7759/cureus.10380.
5
Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients.定量 HBsAg 水平不能识别 HBeAg 阴性慢性乙型肝炎患者的肝纤维化。
Saudi J Gastroenterol. 2019 Sep-Oct;25(5):286-292. doi: 10.4103/sjg.SJG_80_19.
6
Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia.随着年龄的增长，合并症的患病率更高：沙特阿拉伯慢性乙型肝炎患者的横断面分析。
Saudi J Gastroenterol. 2019 May-Jun;25(3):194-200. doi: 10.4103/sjg.SJG_447_18.
7
Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions.沙特阿拉伯的乙肝护理路径：现状、差距与行动
Saudi J Gastroenterol. 2019 Mar-Apr;25(2):73-80. doi: 10.4103/sjg.SJG_421_18.
8
The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease.乙型肝炎病毒前核心/核心区突变与重型肝病进展的相关性。
Front Cell Infect Microbiol. 2018 Oct 22;8:355. doi: 10.3389/fcimb.2018.00355. eCollection 2018.
9
Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.低复制型慢性乙型肝炎中纤维化生物标志物的准确性降低
BMC Gastroenterol. 2017 Aug 25;17(1):101. doi: 10.1186/s12876-017-0658-x.
10
The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia.沙特阿拉伯东部地区青少年和年轻人中乙肝携带率的下降情况。
Saudi Med J. 2016 Aug;37(8):864-70. doi: 10.15537/smj.2016.8.14494.
J Clin Gastroenterol. 2014 Jul;48(6):e50-6. doi: 10.1097/MCG.0b013e3182a9a2e1.
4
Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patients.聚乙二醇干扰素α-2a在HBeAg阴性、初治D基因型患者中的疗效及反应预测因素
Hepatol Int. 2011 Nov 25;6(4):718-26. doi: 10.1007/s12072-011-9319-2. Print 2012 Oct.
5
Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.国际指南识别乙型肝炎 e 抗原阴性慢性乙型肝炎患者显著纤维化的准确性。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.
6
Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology.修订正常肝脏组织学中东人群血清丙氨酸氨基转移酶水平的正常上限。
Dig Dis Sci. 2013 Aug;58(8):2369-75. doi: 10.1007/s10620-013-2659-0. Epub 2013 Mar 30.
7
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.慢性乙型肝炎的管理：加拿大肝脏研究协会共识指南
Can J Gastroenterol. 2012 Dec;26(12):917-38. doi: 10.1155/2012/506819.
8
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.富马酸替诺福韦二吡呋酯治疗慢性乙型肝炎时肝硬化的逆转：一项 5 年开放标签随访研究。
Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10.
9
Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students.美国疾病预防控制中心更新了乙型肝炎病毒感染者医护人员和学生管理建议。
MMWR Recomm Rep. 2012 Jul 6;61(RR-3):1-12.
10
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.欧洲肝脏研究学会临床实践指南：慢性乙型肝炎病毒感染的管理
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.